Strebkova, E., et al. Evaluation of the Effect of mTOR Expression on the Clinical Manifestations of Knee Osteoarthritis in Obese and Normal Weight Patients. Annals of Rheumatic Diseases 2021(80):1
Nousbeck, J., et al. miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a. British Journal of Dermatology. 01 June 2020. https://doi.org/10.1111/bjd.19254
Dhawan, A. A super-series of extracellular miRNA in cerebrospinal fluid reveals broad patterns associated with neurologic disease. medRxiv preprint doi: https://doi.org/10.1101/2020.05.20.20108472.this version posted May 23, 2020.
Wang, X., et al. Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors. Journal Cancers 2020, 12, 1081; doi:10.3390/cancers12051081.
Murphy, D., et al. Angiogenic and Immunomodulatory Biomarkers in Axitinib-treated Patients with Advanced Renal Cell Carcinoma. Future Oncology (Epub ahead of print) 10.2217/fon-2020-0212
Zhou H., et al. Prognostic Factors, Therapeutic Approaches, and Distinct Immunobiologic Features in Patients with Primary Mediastinal Large B-cell Lymphoma on Long-term Follow-up. Blood Cancer Journal (2020)10:49
Ebrahimi, G., et al. Serum Versus Peripheral Blood Mononuclear Cells (PBMCs): Different MicroRNA Profiles in Sarcoidosis Patients. American Journal of Respitory and Critical Care Medicine AJRCCM (2020) Abstract B35
Buschur, K., et al. Vaping-Associated Variation in MicroRNA Expression in Circulating Extraceullular Vesicles. American Journal of Respitory and Critical Care Medicine AJRCCM (2020) Abstract A29.
Ikram, M. A., et al. Objectives, Design and Main Findings Until 2020 From The Rotterdam Study. Eur J of Epidemiol (2020). https://doi.org/10.1007/s10654-020-00640-5
Mens, M., et al. Multi-Omics Analysis Reveals MicroRNAs Associated With Cardiometabolic Traits. Frontiers in Genetics 2020 Feb 27 https://doi.org/10.3389/fgene.2020.00110
Cecchi, I., et al. Circulating microRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment With Rituximab in Systemic Lupus Erythematosus Patients. Autoimmunity Reviews 2020; 9(202) article 102488 In Press
Page last updated November 29, 2022